ANDi

Last updated

ANDi is the first genetically modified rhesus monkey, who was born at Oregon Health Sciences University (OHSU) on October 1, 2001. OHSU named the monkey ANDi because it stands for iDNA spelled backward.

Contents

Birth circumstances

ANDi was born with an extra glowing gene called green fluorescent protein (GFP) [1] . This GFP gene, which is naturally occurring in jellyfish, was taken from a jellyfish and genetically added to ANDi's DNA sequence through his chromosomes. [2] OHSU used rhesus monkeys because they share 95% of the same genes as humans.

Genetic modification method

During the method in which ANDi was created, 224 eggs were injected with the protein and only 166 or 75% were successfully fertilized. 126 or 76% of these fertilized eggs developed to the four-cell-stage embryos. 40 of the fertilized embryos were implanted in 20 surrogate rhesus mothers, each carrying two embryos. 5 of the surrogates became pregnant. From these five surrogates, three live births proceeded. In these three monkey births, only one infant, ANDi, carried the transgene. [3] Research team leader Gerald Schatten said the technique that created ANDi would become a vital tool for scientists investigating therapies for human diseases. [4]

Implications

By being able to genetically modify a monkey, a new breakthrough in technology was formed. ANDi was created in the hope of finding a cure for complicated human diseases such as cancer. [5] Since ANDi was born, scientists want to introduce more significant DNA changes. Scientists are looking to make genetic modifications such as those that would make primates closely mimic human diseases like breast cancer or HIV. [6] Scientists also want to try to study and cure other diseases through trans genetics such as Alzheimer's, AIDS, and diabetes. [4]

Although ANDi carries the gene, it does not appear to be functional; ANDi does not actually glow. [7]

See also

Related Research Articles

<span class="mw-page-title-main">Cloning</span> Process of producing individual organisms with identical genomes

Cloning is the process of producing individual organisms with identical genomes, either by natural or artificial means. In nature, some organisms produce clones through asexual reproduction; this reproduction of an organism by itself without a mate is known as parthenogenesis. In the field of biotechnology, cloning is the process of creating cloned organisms of cells and of DNA fragments.

<span class="mw-page-title-main">Genetically modified organism</span> Organisms whose genetic material has been altered using genetic engineering methods

A genetically modified organism (GMO) is any organism whose genetic material has been altered using genetic engineering techniques. The exact definition of a genetically modified organism and what constitutes genetic engineering varies, with the most common being an organism altered in a way that "does not occur naturally by mating and/or natural recombination". A wide variety of organisms have been genetically modified (GM), including animals, plants, and microorganisms.

<span class="mw-page-title-main">Genetic engineering</span> Manipulation of an organisms genome

Genetic engineering, also called genetic modification or genetic manipulation, is the modification and manipulation of an organism's genes using technology. It is a set of technologies used to change the genetic makeup of cells, including the transfer of genes within and across species boundaries to produce improved or novel organisms. New DNA is obtained by either isolating and copying the genetic material of interest using recombinant DNA methods or by artificially synthesising the DNA. A construct is usually created and used to insert this DNA into the host organism. The first recombinant DNA molecule was made by Paul Berg in 1972 by combining DNA from the monkey virus SV40 with the lambda virus. As well as inserting genes, the process can be used to remove, or "knock out", genes. The new DNA can be inserted randomly, or targeted to a specific part of the genome.

<span class="mw-page-title-main">Chimera (genetics)</span> Single organism composed of two or more different populations of genetically distinct cells

A genetic chimerism or chimera is a single organism composed of cells with more than one distinct genotype. In animals and human chimeras, this means an individual derived from two or more zygotes, which can include possessing blood cells of different blood types, and subtle variations in form (phenotype). Animal chimeras are produced by the merger of two embryos. In plant chimeras, however, the distinct types of tissue may originate from the same zygote, and the difference is often due to mutation during ordinary cell division. Normally, genetic chimerism is not visible on casual inspection; however, it has been detected in the course of proving parentage. In contrast, an individual where each cell contains genetic material from two organisms of different breeds, varieties, species or genera is called a hybrid.

<i>Simian immunodeficiency virus</i> Species of retrovirus

Simian immunodeficiency virus (SIV) is a species of retrovirus that cause persistent infections in at least 45 species of non-human primates. Based on analysis of strains found in four species of monkeys from Bioko Island, which was isolated from the mainland by rising sea levels about 11,000 years ago, it has been concluded that SIV has been present in monkeys and apes for at least 32,000 years, and probably much longer.

<span class="mw-page-title-main">Rhesus macaque</span> Species of Old World monkey

The rhesus macaque, colloquially rhesus monkey, is a species of Old World monkey. There are between six and nine recognised subspecies that are split between two groups, the Chinese-derived and the Indian-derived. Generally brown or grey in colour, it is 47–53 cm (19–21 in) in length with a 20.7–22.9 cm (8.1–9.0 in) tail and weighs 5.3–7.7 kg (12–17 lb). It is native to South, Central, and Southeast Asia and has the widest geographic range of all non-human primates, occupying a great diversity of altitudes and a great variety of habitats, from grasslands to arid and forested areas, but also close to human settlements. Feral colonies are found in the United States, thought to be either released by humans or escapees after hurricanes destroyed zoo and wildlife park facilities.

The term modifications in genetics refers to both naturally occurring and engineered changes in DNA. Incidental, or natural mutations occur through errors during replication and repair, either spontaneously or due to environmental stressors. Intentional modifications are done in a laboratory for various purposes, developing hardier seeds and plants, and increasingly to treat human disease. The use of gene editing technology remains controversial.

<span class="mw-page-title-main">Oregon National Primate Research Center</span>

The Oregon National Primate Research Center (ONPRC) is one of seven federally funded National Primate Research Centers in the United States and has been affiliated with Oregon Health and Science University (OHSU) since 1998. The center is located on 200 acres (0.81 km2) of land in Hillsboro, Oregon. Originally known as the Oregon Regional Primate Research Center (ORPRC), it was the first of the original seven primate centers established by the National Institutes of Health (NIH). The research center is administered and funded by the National Center for Research Resources, receiving $11 million in federal grants annually.

Tetra is a rhesus macaque that was created through a cloning technique called "embryo splitting". She is the first "cloned" primate by artificial twinning, and was created by a team led by Professor Gerald Schatten of the Oregon National Primate Research Center.

pGLO

The pGLO plasmid is an engineered plasmid used in biotechnology as a vector for creating genetically modified organisms. The plasmid contains several reporter genes, most notably the green fluorescent protein (GFP) and the ampicillin resistance gene. GFP was isolated from the jelly fish Aequorea victoria. Because it shares a bidirectional promoter with a gene for metabolizing arabinose, the GFP gene is expressed in the presence of arabinose, which makes the transgenic organism express its fluorescence under UV light. GFP can be induced in bacteria containing the pGLO plasmid by growing them on +arabinose plates. pGLO is made by Bio-Rad Laboratories.

Gerald Schatten is an American stem cell researcher with interests in cell, developmental, and reproductive biology. He is Professor and vice-chair of Obstetrics, Gynecology and Reproductive Sciences and Professor of Cell Biology and of Bioengineering in the Schools of Medicine and Engineering at the University of Pittsburgh, where he is also Director of the Division of Developmental and Regenerative Medicine at the university's School of Medicine. Additionally, he is deputy director of the Magee-Women's Research Institute and Director of the Pittsburgh Development Center.. He is a member of the NCI-designated University of Pittsburgh Cancer Center and the McGowan Institute for Regenerative Medicine.

A transgene is a gene that has been transferred naturally, or by any of a number of genetic engineering techniques, from one organism to another. The introduction of a transgene, in a process known as transgenesis, has the potential to change the phenotype of an organism. Transgene describes a segment of DNA containing a gene sequence that has been isolated from one organism and is introduced into a different organism. This non-native segment of DNA may either retain the ability to produce RNA or protein in the transgenic organism or alter the normal function of the transgenic organism's genetic code. In general, the DNA is incorporated into the organism's germ line. For example, in higher vertebrates this can be accomplished by injecting the foreign DNA into the nucleus of a fertilized ovum. This technique is routinely used to introduce human disease genes or other genes of interest into strains of laboratory mice to study the function or pathology involved with that particular gene.

<span class="mw-page-title-main">Genetically modified animal</span> Animal that has been genetically modified

Genetically modified animals are animals that have been genetically modified for a variety of purposes including producing drugs, enhancing yields, increasing resistance to disease, etc. The vast majority of genetically modified animals are at the research stage while the number close to entering the market remains small.

<span class="mw-page-title-main">Genetically modified mammal</span>

Genetically modified mammals are mammals that have been genetically engineered. They are an important category of genetically modified organisms. The majority of research involving genetically modified mammals involves mice with attempts to produce knockout animals in other mammalian species limited by the inability to derive and stably culture embryonic stem cells.

Mitochondrial replacement therapy (MRT), sometimes called mitochondrial donation, is the replacement of mitochondria in one or more cells to prevent or ameliorate disease. MRT originated as a special form of in vitro fertilisation in which some or all of the future baby's mitochondrial DNA (mtDNA) comes from a third party. This technique is used in cases when mothers carry genes for mitochondrial diseases. The therapy is approved for use in the United Kingdom. A second application is to use autologous mitochondria to replace mitochondria in damaged tissue to restore the tissue to a functional state. This has been used in clinical research in the United States to treat cardiac-compromised newborns.

Laura Charlotte Hewitson is a British-born primate researcher noted for her work in the fields of reproductive biology and behavior. She is an affiliate scientist at the Washington National Primate Research Center (WaNPRC) and an adjunct associate professor of psychiatry at the University of Texas Southwestern Medical Center. Additionally, she is the Research Director of the Johnson Center for Child Health and Development in Austin, Texas. Hewitson was a staff scientist at Oregon Health Sciences University from 1997 to 2001. From 2002 to 2010 she was an associate professor of obstetrics, gynecology and reproductive sciences at the University of Pittsburgh School of Medicine and a member of the Magee-Women's Research Institute and Foundation (MWRI&F) in Pittsburgh, Pennsylvania.

<span class="mw-page-title-main">Juan Carlos Izpisua Belmonte</span> Spanish biochemist and developmental biologist

Juan Carlos Izpisua Belmonte is a Spanish biochemist and developmental biologist. He is a professor in the Gene Expression Laboratories at the Salk Institute for Biological Studies in La Jolla, California since 1993.

Shoukhrat Mitalipov is an American biologist who heads the Center for Embryonic Cell and Gene Therapy at the Oregon Health & Science University in Portland. He is a well known pioneer of many nuclear transplantation studies and was named in 2013 by journal Nature as "the cloning chief". Mitalipov is also a godfather of a gene therapy, known as mitochondrial replacement therapy, that prevents inheritance of mitochondrial diseases. He discovered a new way of creating human stem cells from skin cells.

Human germline engineering is the process by which the genome of an individual is edited in such a way that the change is heritable. This is achieved by altering the genes of the germ cells, which then mature into genetically modified eggs and sperm. For safety, ethical, and social reasons, there is broad agreement among the scientific community and the public that germline editing for reproduction is a red line that should not be crossed at this point in time. There are differing public sentiments, however, on whether it may be performed in the future depending on whether the intent would be therapeutic or non-therapeutic.

<span class="mw-page-title-main">Zhong Zhong and Hua Hua</span> Worlds first cloned primates (born 2017)

Zhong Zhong and Hua Hua are a pair of identical crab-eating macaques that were created through somatic cell nuclear transfer (SCNT), the same cloning technique that produced Dolly the sheep in 1996. They are the first cloned primates produced by this technique. Unlike previous attempts to clone monkeys, the donated nuclei came from fetal cells, not embryonic cells. The primates were born from two independent surrogate pregnancies at the Institute of Neuroscience of the Chinese Academy of Sciences in Shanghai.

References

  1. Chan, AWS; et al. (2001). "Transgenic Monkeys Produced by Retroviral Gene Transfer into Mature Oocytes". Science. 291 (5502): 309–312. doi:10.1126/science.291.5502.309. PMID   11209082.
  2. Chiang, Mona (12 February 2001). "Monkey See, Monkey Glow" . Science World. p. 7. Retrieved 5 December 2011.
  3. Dunnett, Stephen (May 2001). "Reverse transcription of inserted DNA in a monkey gives us ANDi". Trends in Pharmacological Sciences. 22 (5): 211–214. doi:10.1016/s0165-6147(00)01707-7. PMID   11339958.
  4. 1 2 "Glowing future for GM monkey". The Australian: 12.
  5. Sawicki, Stephen (2001). "Genetic Engineering Results in First Primate Deliberately Mutated". Animals: 2.
  6. McCall, WilliM. "Meet ANDi the first GM monkey" via EBSCO Host.{{cite journal}}: Cite journal requires |journal= (help)
  7. Coghlan, Andy. "GM monkey passes jellyfish gene to offspring". New Scientist. Retrieved 13 December 2013.